Cochlear, Wesfarmers, ERA, NAB, ANZ and CBA – are they on Roger Montgomery’s stocks to buy list?
Cochlear is one of the great success stories of Australian business and its value is rising over the next few years, but is it cheap? Can Wesfarmers ever recover following the overpriced Coles acquisition? And ANZ and NAB – Back in August 2009 Roger Montgomery said buy CBA, Australia’s superior bank, but now its expensive. ANZ is cheap and NAB is expensive, but they are inferior businesses to CBA. Visit Rogers blog, rogermontgomery.com, for his latest comments on NAB and ANZ. Watch the interview.
Roger Montgomery is the Founder and Chairman of Montgomery Investment Management. Roger has over three decades of experience in funds management and related activities, including equities analysis, equity and derivatives strategy, trading and stockbroking. Prior to establishing Montgomery, Roger held positions at Ord Minnett Jardine Fleming, BT (Australia) Limited and Merrill Lynch.
This post was contributed by a representative of Montgomery Investment Management Pty Limited (AFSL No. 354564). The principal purpose of this post is to provide factual information and not provide financial product advice. Additionally, the information provided is not intended to provide any recommendation or opinion about any financial product. Any commentary and statements of opinion however may contain general advice only that is prepared without taking into account your personal objectives, financial circumstances or needs. Because of this, before acting on any of the information provided, you should always consider its appropriateness in light of your personal objectives, financial circumstances and needs and should consider seeking independent advice from a financial advisor if necessary before making any decisions. This post specifically excludes personal advice.
